Alda Pharmaceuticals reinstated for trading

2012-03-09 20:19 ET - Cease Trade Company Rescinded

Further to the TSX Venture Exchange bulletins dated Nov. 4, 2011, and March 7, 2012, the exchange has been advised that the cease trade order issued by the British Columbia Securities Commission on Nov. 4, 2011, has been revoked.

Effective at the opening Monday, March 12, 2012, trading will be reinstated in the securities of Alda Pharmaceuticals Corp. (Cusip 01407W 20 5).

ALDA PHARMACEUTICALS CORP. ("APH")
BULLETIN TYPE: Consolidation, Remain Suspended
BULLETIN DATE: March 7, 2012
TSX Venture Tier 2 Company

Pursuant to a special resolution passed by shareholders January 27, 2012, the Company has consolidated its capital on a 10 old for 1 new basis and has subsequently increased its authorized capital. The name of the Company has not been changed.

Effective at the opening, Thursday, March 8, 2012, the shares of ALDA Pharmaceuticals Corp. will be listed on TSX Venture Exchange on a consolidated basis; however, the shares of the Company will remain suspended from trading. The Company is classified as a 'Developing, manufacturing and selling infection control products' company.


Post - Consolidation
Capitalization: Unlimited shares with no par value of which
6,399,680 shares are issued and outstanding
Escrow: Nil shares are subject to escrow


Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: APH (UNCHANGED)
CUSIP Number: 01407W 20 5 (new)

Alda Pharmaceuticals shareholders pass AGM resolutions

2012-01-30 17:14 ET - News Release


Mr. Terrance Owen reports

ALDA AGM HELD ON JANUARY 27, 2012

Alda Pharmaceuticals Corp.'s annual general meeting of shareholders was held in Vancouver, B.C., on Jan. 27, 2012, at which:


The number of directors was set at five.


Five incumbent directors of the company, being Terrance Owen, Peter Chen, Linda Allison, Ronald Zokol and William F. McCoy were re-elected as directors of Alda for the coming year.


MNP LLP, chartered accountants, was appointed as the new auditor of Alda for the coming year, in accordance with the policies of the TSX Venture Exchange.


The company's rolling 2003 incentive stock option plan, as amended, was ratified for the coming year.


A consolidation of the company's common shares such that one new common share would be issued for every 20 old common shares outstanding, or such lower consolidation ratio as may be determined by the directors of Alda Pharmaceuticals, was approved.

We seek Safe Harbor.

ALDA Pharmaceuticals to Undertake Revised Private Placement

VANCOUVER, BRITISH COLUMBIA, Jul 27, 2010 (MARKETWIRE via COMTEX News Network) --

ALDA Pharmaceuticals Corp. (TSX VENTURE: APH)(OTCQB: APCSF)(PINK SHEETS: APCSF) (the "Company") announces that, as a result of prevailing market conditions, the private placement financing originally announced on April 15, 2010 (and subsequently revised as disclosed in the Company's news releases of April 28th and May 28th), will not be proceeding on the terms disclosed. The Company is proceeding with a smaller private placement of $325,000 to be used for general corporate purposes by the sale of 3,250,000 share purchase units on a private placement basis, pursuant to registration and prospectus exemptions of applicable securities laws and is subject to acceptance by the TSX Venture Exchange, at $0.10 per unit. Each Unit consists of one common share of ALDA and one non-transferable share purchase warrant entitling the holder to acquire one additional common share of ALDA at a price of $0.20 per common share for a period of two (2) years from the date of the issuance of the purchase warrant with an accelerated exercise provision attached to each warrant commencing on the day following the expiry of any applicable hold period on the underlying Common Share, stating that if, for ten consecutive trading days, the closing price of the listed shares of the Company exceeds $0.40 then the exercise period of the warrants will be reduced to a period of 10 days following such trading days. All securities issued will be subject to a four month restricted period and will bear a restrictive legend accordingly.

Insiders of ALDA will be subscribing for 25% of the offering, constituting a related party transaction pursuant to Multilateral Instrument 61-101 and TSX Venture Exchange Policy 5.9 which is exempt from the requirement to obtain an independent valuation pursuant to Section 5.5(b) of MI 61-101 and the requirement to obtain minority shareholder approval pursuant to Section 5.7(1)(b) of MI 61-101. Their participation will be on the same terms as arm's length investors, and such insiders' shareholdings in the Company will increase as a result of any such participation. The revised private placement is intended to close within the next week as soon as the requisite approvals of the TSX Venture Exchange are obtained.

The Company also wishes to clarify that a report on the TSX Venture Exchange website on Tuesday, July 20, 2010 that an insider sold 108,500 shares at $0.12 was not correct. The Company has confirmed that the transaction did not involve a current insider of the Company and was incorrectly designated as such on the TSX Venture Exchange website.

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The Company trades on the TSX Venture Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning products. The Company was also selected as one of the TSX Venture 50 companies in the Technology and Life Sciences sector for 2010.

Terrance G. Owen, Ph.D., MBA, President & CEO, ALDA Pharmaceuticals Corp.

The Units, common shares, warrants and the common shares issuable upon exercise of the warrants have not been registered under the United States Securities Act of 1933 (the "Act") and may not be offered or sold absent registration under the Act or an applicable exemption from the registration requirements thereof. This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or an exemption therefrom.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook", "will", "could", "would", "might", "remains", "to be", "plans", "believes", "may", "expects", "intends", "anticipates", "estimate", "future", "plan", "positioned", "potential", "project", "remain", "scheduled", "set to", "subject to", "upcoming", and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts: ALDA Pharmaceuticals Corp. Scott Young Investor Relations 604-377-5781 or 604-521-8300 Ext 2 604-521-8322 (FAX) scott_young@aldacorp.com www.aldacorp.com

SOURCE: ALDA Pharmaceuticals Corp.

mailto:scott_young@aldacorp.com http://www.aldacorp.com

Copyright 2010 Marketwire, Inc., All rights reserved.

First Two Holes Cut Mineralized Zones

MIRAMICHI, NB, June 21 /CNW/ - SLAM Exploration Ltd. (TSX-V:SXL) ("SLAM") announces drilling results from the first two holes on its wholly owned Reserve Creek project in the Fort Hope area of Ontario. Visible gold occurs in both holes within sulphide-bearing intervals ranging from 10 to 39 feet (3 to 11.8 m) in core length.

Visible gold occurs at a depth of 3.55 m in hole RC10-14. Visible gold also occurs at 10.9 m and 11.2 m within a 10 foot (3.1 m) mineralized core interval containing 10% sulphides (pyrrhotite-pyrite) at a depth of 9.2 m. A second 20 foot (6.0 m) zone starting at 18.0 m contains 5% sulphide mineralization. The hole stopped at 56.35 m.

Visible gold occurs in the second hole, RC10-15 at 16.9 m within a 19 foot (5.9 m) mineralized core interval containing 10% sulphides starting at a depth of 12.6 m. At 22.2 m, the hole cut a 39 foot (11.8 m) mineralized core interval with 5% sulphides and visible gold at 42.5 m. These mineralized zones occur within a 123 foot (37.4 m) interval of magnetite-bearing tuffs from 12.6 m to 50.0 m.

The initial drilling phase of the program is now complete with 3 holes drilled at Reserve Creek. All three holes were drilled from one collar set-up to test the Williamson gold deposit. The first hole intersected the zone near-surface. The second hole tested the zone to a depth of 50 m. The 3rd hole was drilled to a depth of 195 metres to test the zone and potential extensions at depth beneath the second hole. This hole, RC10-16 is currently being evaluated and information will be published when available.

The Fort Hope gold area is located east of the historic Pickle Lake gold camp where PC Gold Inc. (TSE:PKL) recently announced successful drilling results (press release 23 March 2010). The Fort Hope and Pickle Lake areas are underlain by Uchi Subprovince rocks similar to the world-famous Red Lake gold mining camp.

Michael R. Taylor, P.Geo. President and CEO of SLAM, is the Qualified Person responsible for management of the Reserve Creek drilling program and for the technical information contained herein. The mineralized zones described above are drilled core intervals. The true widths are unknown.

The drilling activities have been performed in consultation with Eabametoong First Nation ("EFN") in accordance with a recently signed Exploration Agreement. This Agreement calls for EFN and SLAM to work cooperatively to advance the gold potential of the Fort Hope area.

About SLAM: SLAM is a mineral resource company based in Miramichi, New Brunswick and continues to be active in gold, silver and base metal exploration in Ontario and New Brunswick. Additional information about SLAM and its projects is available at www.slamexploration.com or from SEDAR filings at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    <<

    On behalf of the Board


        Mike Taylor, P. Geo.

        President & CEO

        SLAM Exploration Ltd.

        SEDAR: 00012459E

    >>

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

This release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements in this release, other than statements of historical fact, that address future production, reserve potential, exploration and development activities and events or developments that SLAM expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward looking statements. Please see our public filings at www.sedar.com for further information.

%SEDAR: 00012459E

View SLAM Profile As Featured By CEO Clips

MIRAMICHI, NB, June 21 /CNW/ - SLAM Exploration Ltd. (TSX-V:SXL) ("SLAM") announces it will be featured by CEO Clips airing on BNN:

Monday June 21 to 27, 2010 and June 28 to Jul 4, 2010: CEO Clips, a series of 30 second corporate profiles on Canadian companies, will feature SLAM Exploration Ltd. on BNN beginning Monday, June 21, 2010. It can also be viewed online via this link:

http://www.b-tv.com/features/watch-now.html?clip=BNNSlam30.wmv.

In addition it will be posted on Yahoo Finance Canada, stockhouse.ca and MSN Finance as well as www.ceoclips.com.

About BNN:

Business News Network (BNN) is Canada's only all business specialty channel with real time coverage of global market activity from a Canadian perspective.

Michael R. Taylor, P.Geo. President and CEO of SLAM Exploration Ltd. is the Qualified Person responsible for the technical information contained herein.

SLAM is a mineral resource company based in Miramichi, New Brunswick and continues to be active in gold, silver and base metal exploration in Ontario and New Brunswick. Additional information about SLAM and its projects is available at www.slamexploration.com or from SEDAR filings at www.sedar.com. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Additional information about SLAM can be viewed at http://www.slamexploration.com as well at www.sedar.com.

    <<

    On behalf of the Board


        Mike Taylor, P. Geo.

        President & CEO

        SLAM Exploration Ltd.

        SEDAR: 00012459E

    >>

This release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements in this release, other than statements of historical fact, that address future production, reserve potential, exploration and development activities and events or developments that SLAM expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward looking statements. Please see our public filings at www.sedar.com for further information.

%SEDAR: 00012459E